# Question 67

**Type:** Genomic Alterationâ€“Subtype Association

**Question:** In the TCGA Breast Cancer study if a patient has both a PIK3CA mutation and a PTEN deletion what is their probability of having a luminal A subtype? Is this probability different from a patient with only a PIK3CA mutation?

**Answer:**

I'll help you analyze the relationship between PIK3CA mutations, PTEN deletions, and luminal A subtype in the TCGA Breast Cancer study. Let me start by finding the correct study and then querying the data.



Calling `list_studies` with args:
```json
{
  "search": "TCGA breast"
}
```



Result from `list_studies`:
```json

```




Calling `list_studies` with args:
```json
{
  "search": "breast",
  "limit": 30
}
```



Result from `list_studies`:
```json
[{"cancer_study_identifier":"breast_msk_2025","name":"Breast Cancer (MSK, 2025)","type_of_cancer_id":"brca","sample_count":3880,"has_guide":false},{"cancer_study_identifier":"breast_msk_2018","name":"Breast Cancer (MSK, Cancer Cell 2018)","type_of_cancer_id":"breast","sample_count":1919,"has_guide":false},{"cancer_study_identifier":"breast_ink4_msk_2021","name":"Metastatic Breast Cancer (MSK, Cancer Discovery 2022)","type_of_cancer_id":"breast","sample_count":1366,"has_guide":false},{"cancer_study_identifier":"breast_cptac_gdc","name":"Breast Cancer (CPTAC GDC, 2025)","type_of_cancer_id":"breast","sample_count":155,"has_guide":false},{"cancer_study_identifier":"brca_mapk_hp_msk_2021","name":"MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)","type_of_cancer_id":"brca","sample_count":146,"has_guide":false},{"cancer_study_identifier":"breast_alpelisib_2020","name":"Breast Cancer (MSK, Nature Cancer 2020)","type_of_cancer_id":"breast","sample_count":142,"has_guide":false},{"cancer_study_identifier":"brca_cptac_2020","name":"Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)","type_of_cancer_id":"brca","sample_count":123,"has_guide":false},{"cancer_study_identifier":"ilc_msk_2023","name":"Non-CDH1 Invasive Lobular Carcinoma (MSK, 2023)","type_of_cancer_id":"breast","sample_count":26,"has_guide":false}]
```


Let me search more specifically for TCGA:



Calling `list_studies` with args:
```json
{
  "search": "tcga",
  "limit": 50
}
```



Result from `list_studies`:
```json
[{"cancer_study_identifier":"nsclc_tcga_broad_2016","name":"Pan-Lung Cancer (TCGA, Nat Genet 2016)","type_of_cancer_id":"nsclc","sample_count":1145,"has_guide":false},{"cancer_study_identifier":"lgggbm_tcga_pub","name":"Merged Cohort of LGG and GBM (TCGA, Cell 2016)","type_of_cancer_id":"difg","sample_count":1123,"has_guide":false},{"cancer_study_identifier":"brca_tcga","name":"Breast Invasive Carcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"brca","sample_count":1109,"has_guide":false},{"cancer_study_identifier":"brca_tcga_gdc","name":"Invasive Breast Carcinoma (TCGA, GDC)","type_of_cancer_id":"brca","sample_count":1106,"has_guide":false},{"cancer_study_identifier":"brca_tcga_pan_can_atlas_2018","name":"Breast Invasive Carcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"brca","sample_count":1085,"has_guide":true},{"cancer_study_identifier":"brca_tcga_pub","name":"Breast Invasive Carcinoma (TCGA, Nature 2012)","type_of_cancer_id":"brca","sample_count":826,"has_guide":false},{"cancer_study_identifier":"brca_tcga_pub2015","name":"Breast Invasive Carcinoma (TCGA, Cell 2015)","type_of_cancer_id":"brca","sample_count":819,"has_guide":false},{"cancer_study_identifier":"coadread_tcga","name":"Colorectal Adenocarcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"coadread","sample_count":641,"has_guide":false},{"cancer_study_identifier":"gbm_tcga","name":"Glioblastoma Multiforme (TCGA, Firehose Legacy)","type_of_cancer_id":"difg","sample_count":620,"has_guide":false},{"cancer_study_identifier":"ov_tcga","name":"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"hgsoc","sample_count":618,"has_guide":false},{"cancer_study_identifier":"hgsoc_tcga_gdc","name":"High-Grade Serous Ovarian Cancer (TCGA, GDC)","type_of_cancer_id":"hgsoc","sample_count":618,"has_guide":false},{"cancer_study_identifier":"gbm_tcga_gdc","name":"Glioblastoma Multiforme (TCGA GDC, 2025)","type_of_cancer_id":"difg","sample_count":612,"has_guide":false},{"cancer_study_identifier":"coadread_tcga_pan_can_atlas_2018","name":"Colorectal Adenocarcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"coadread","sample_count":595,"has_guide":true},{"cancer_study_identifier":"gbm_tcga_pan_can_atlas_2018","name":"Glioblastoma Multiforme (TCGA, PanCancer Atlas)","type_of_cancer_id":"difg","sample_count":593,"has_guide":true},{"cancer_study_identifier":"luad_tcga_gdc","name":"Lung Adenocarcinoma (TCGA, GDC)","type_of_cancer_id":"luad","sample_count":588,"has_guide":false},{"cancer_study_identifier":"luad_tcga","name":"Lung Adenocarcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"luad","sample_count":587,"has_guide":false},{"cancer_study_identifier":"ov_tcga_pan_can_atlas_2018","name":"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"hgsoc","sample_count":586,"has_guide":true},{"cancer_study_identifier":"gbm_tcga_pub2013","name":"Glioblastoma (TCGA, Cell 2013)","type_of_cancer_id":"difg","sample_count":578,"has_guide":false},{"cancer_study_identifier":"luad_tcga_pan_can_atlas_2018","name":"Lung Adenocarcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"luad","sample_count":567,"has_guide":true},{"cancer_study_identifier":"stes_tcga_pub","name":"Esophageal Carcinoma (TCGA, Nature 2017)","type_of_cancer_id":"egc","sample_count":560,"has_guide":false},{"cancer_study_identifier":"ucec_tcga","name":"Uterine Corpus Endometrial Carcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"ucec","sample_count":550,"has_guide":false},{"cancer_study_identifier":"ucec_tcga_gdc","name":"Endometrial Carcinoma (TCGA, GDC)","type_of_cancer_id":"ucec","sample_count":550,"has_guide":false},{"cancer_study_identifier":"kirc_tcga","name":"Kidney Renal Clear Cell Carcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"ccrcc","sample_count":539,"has_guide":false},{"cancer_study_identifier":"ccrcc_tcga_gdc","name":"Renal Clear Cell Carcinoma (TCGA, GDC)","type_of_cancer_id":"ccrcc","sample_count":539,"has_guide":false},{"cancer_study_identifier":"difg_tcga_gdc","name":"Diffuse Glioma (TCGA, GDC)","type_of_cancer_id":"difg","sample_count":533,"has_guide":false},{"cancer_study_identifier":"hnsc_tcga","name":"Head and Neck Squamous Cell Carcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"hnsc","sample_count":531,"has_guide":false},{"cancer_study_identifier":"lgg_tcga","name":"Brain Lower Grade Glioma (TCGA, Firehose Legacy)","type_of_cancer_id":"difg","sample_count":531,"has_guide":false},{"cancer_study_identifier":"hnsc_tcga_gdc","name":"Head and Neck Squamous Cell Carcinoma (TCGA, GDC)","type_of_cancer_id":"hnsc","sample_count":531,"has_guide":false},{"cancer_study_identifier":"ucec_tcga_pan_can_atlas_2018","name":"Uterine Corpus Endometrial Carcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"ucec","sample_count":530,"has_guide":true},{"cancer_study_identifier":"hnsc_tcga_pan_can_atlas_2018","name":"Head and Neck Squamous Cell Carcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"hnsc","sample_count":524,"has_guide":false},{"cancer_study_identifier":"thca_tcga","name":"Thyroid Carcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"thpa","sample_count":517,"has_guide":false},{"cancer_study_identifier":"thpa_tcga_gdc","name":"Papillary Thyroid Cancer (TCGA, GDC)","type_of_cancer_id":"thpa","sample_count":516,"has_guide":false},{"cancer_study_identifier":"lgg_tcga_pan_can_atlas_2018","name":"Brain Lower Grade Glioma (TCGA, PanCancer Atlas)","type_of_cancer_id":"difg","sample_count":515,"has_guide":false},{"cancer_study_identifier":"kirc_tcga_pan_can_atlas_2018","name":"Kidney Renal Clear Cell Carcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"ccrcc","sample_count":513,"has_guide":false},{"cancer_study_identifier":"lusc_tcga","name":"Lung Squamous Cell Carcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"lusc","sample_count":512,"has_guide":false},{"cancer_study_identifier":"lusc_tcga_gdc","name":"Lung Squamous Cell Carcinoma (TCGA, GDC)","type_of_cancer_id":"lusc","sample_count":505,"has_guide":false},{"cancer_study_identifier":"prad_tcga_gdc","name":"Prostate Adenocarcinoma (TCGA, GDC)","type_of_cancer_id":"prad","sample_count":502,"has_guide":false},{"cancer_study_identifier":"prad_tcga","name":"Prostate Adenocarcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"prad","sample_count":502,"has_guide":false},{"cancer_study_identifier":"thca_tcga_pan_can_atlas_2018","name":"Thyroid Carcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"thpa","sample_count":501,"has_guide":false},{"cancer_study_identifier":"thca_tcga_pub","name":"Papillary Thyroid Carcinoma (TCGA, Cell 2014)","type_of_cancer_id":"thpa","sample_count":497,"has_guide":false},{"cancer_study_identifier":"prad_tcga_pan_can_atlas_2018","name":"Prostate Adenocarcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"prad","sample_count":495,"has_guide":false},{"cancer_study_identifier":"ov_tcga_pub","name":"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)","type_of_cancer_id":"hgsoc","sample_count":490,"has_guide":false},{"cancer_study_identifier":"lusc_tcga_pan_can_atlas_2018","name":"Lung Squamous Cell Carcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"lusc","sample_count":488,"has_guide":false},{"cancer_study_identifier":"skcm_tcga","name":"Skin Cutaneous Melanoma (TCGA, Firehose Legacy)","type_of_cancer_id":"skcm","sample_count":481,"has_guide":false},{"cancer_study_identifier":"stad_tcga","name":"Stomach Adenocarcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"stad","sample_count":479,"has_guide":false},{"cancer_study_identifier":"blca_msk_tcga_2020","name":"Bladder Cancer (MSK/TCGA, 2020)","type_of_cancer_id":"blca","sample_count":477,"has_guide":false},{"cancer_study_identifier":"skcm_tcga_gdc","name":"Cutaneous Melanoma (TCGA, GDC)","type_of_cancer_id":"skcm","sample_count":475,"has_guide":false},{"cancer_study_identifier":"coad_tcga_gdc","name":"Colon Adenocarcinoma (TCGA, GDC)","type_of_cancer_id":"coad","sample_count":465,"has_guide":false},{"cancer_study_identifier":"skcm_tcga_pan_can_atlas_2018","name":"Skin Cutaneous Melanoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"skcm","sample_count":449,"has_guide":false},{"cancer_study_identifier":"kirc_tcga_pub","name":"Kidney Renal Clear Cell Carcinoma (TCGA, Nature 2013)","type_of_cancer_id":"ccrcc","sample_count":447,"has_guide":false}]
```


Great! I found several TCGA Breast Cancer studies. I'll use the PanCancer Atlas version which has a guide available. Let me get the study guide first:



Calling `get_study_guide` with args:
```json
{
  "study_id": "brca_tcga_pan_can_atlas_2018"
}
```



Result from `get_study_guide`:
```json
# Breast Invasive Carcinoma (TCGA, PanCancer Atlas)

**Study ID:** `brca_tcga_pan_can_atlas_2018`

See `_tcga_pancan_template.md` for common TCGA clinical attributes.

## Study-Specific Attributes

### Molecular Subtypes
| Attribute | Description | Values |
|-----------|-------------|--------|
| `SUBTYPE` | PAM50 molecular subtype | Luminal A, Luminal B, HER2-enriched, Basal-like, Normal-like |

### Receptor Status
| Attribute | Description | Notes |
|-----------|-------------|-------|
| `ER_STATUS` | Estrogen receptor status | Positive, Negative |
| `PR_STATUS` | Progesterone receptor status | Positive, Negative |
| `HER2_STATUS` | HER2 receptor status | Positive, Negative, Equivocal |
| `TRIPLE_NEGATIVE` | Triple negative status | Derived from ER/PR/HER2 |

### Histology
| Attribute | Description |
|-----------|-------------|
| `HISTOLOGICAL_TYPE` | Ductal, Lobular, Mixed, etc. |

## Key Genes
- **TP53**: Most frequently mutated (~30%)
- **PIK3CA**: Common in ER+ tumors (~35%)
- **CDH1**: Enriched in lobular carcinoma
- **GATA3**: Luminal marker
- **ERBB2**: HER2 amplification target

## Notes
- Molecular subtypes (PAM50) correlate strongly with clinical behavior
- ER/PR/HER2 status drives treatment decisions
- Lobular vs ductal distinction has different mutation profiles

```


Perfect! Now I'll query the data to find:
1. Patients with both PIK3CA mutation AND PTEN deletion
2. Patients with only PIK3CA mutation (no PTEN deletion)
3. Calculate the probability of luminal A subtype for each group



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- First, let's identify patients with PIK3CA mutations and PTEN deletions\nWITH patient_alterations AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        hugo_gene_symbol,\n        variant_type,\n        CASE \n            WHEN variant_type = 'mutation' THEN 'mutation'\n            WHEN variant_type = 'cna' AND alteration IN (-2) THEN 'deletion'\n            ELSE NULL\n        END as alteration_type\n    FROM genomic_event_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND hugo_gene_symbol IN ('PIK3CA', 'PTEN')\n        AND (\n            (variant_type = 'mutation') OR \n            (variant_type = 'cna' AND alteration = -2)\n        )\n),\npatient_groups AS (\n    SELECT \n        patient_unique_id,\n        MAX(CASE WHEN hugo_gene_symbol = 'PIK3CA' AND alteration_type = 'mutation' THEN 1 ELSE 0 END) as has_pik3ca_mut,\n        MAX(CASE WHEN hugo_gene_symbol = 'PTEN' AND alteration_type = 'deletion' THEN 1 ELSE 0 END) as has_pten_del\n    FROM patient_alterations\n    GROUP BY patient_unique_id\n),\npatient_subtypes AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        attribute_value as subtype\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND attribute_name = 'SUBTYPE'\n)\nSELECT \n    CASE \n        WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 1 THEN 'PIK3CA mutation + PTEN deletion'\n        WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 0 THEN 'PIK3CA mutation only'\n        ELSE 'Other'\n    END as patient_group,\n    COUNT(DISTINCT pg.patient_unique_id) as total_patients,\n    SUM(CASE WHEN ps.subtype = 'LumA' THEN 1 ELSE 0 END) as luminal_a_count,\n    ROUND(SUM(CASE WHEN ps.subtype = 'LumA' THEN 1 ELSE 0 END) * 100.0 / COUNT(DISTINCT pg.patient_unique_id), 2) as luminal_a_percentage\nFROM patient_groups pg\nLEFT JOIN patient_subtypes ps ON pg.patient_unique_id = ps.patient_unique_id\nWHERE pg.has_pik3ca_mut = 1\nGROUP BY patient_group\nORDER BY patient_group\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"error_message":"Query execution failed: Received ClickHouse exception, code: 47, server response: Code: 47. DB::Exception: Unknown expression or table expression identifier `alteration` in scope patient_alterations AS (SELECT DISTINCT patient_unique_id, hugo_gene_symbol, variant_type, multiIf(variant_type = 'mutation', 'mutation', (variant_type = 'cna') AND (alteration IN (-2)), 'deletion', NULL) AS alteration_type FROM genomic_event_derived WHERE (cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018') AND (hugo_gene_symbol IN ('PIK3CA', 'PTEN')) AND ((variant_type = 'mutation') OR ((variant_type = 'cna') AND (alteration = -2)))). (UNKNOWN_IDENTIFIER) (version 25.8.1.36912 (official build)) (for url https://dl96orhu96.us-east-1.aws.clickhouse.cloud:8443)"}
```


Let me check the columns available in genomic_event_derived:



Calling `clickhouse_list_table_columns` with args:
```json
{
  "table": "genomic_event_derived"
}
```



Result from `clickhouse_list_table_columns`:
```json
{"columns":[{"name":"sample_unique_id","type":"String","comment":"Globally unique sample identifier constructed as cancer_study_identifier + \"_\" + sample.stable_id to ensure uniqueness across all studies."},{"name":"hugo_gene_symbol","type":"String","comment":"Official HUGO gene symbol for the affected gene. References gene.hugo_gene_symbol."},{"name":"entrez_gene_id","type":"Int32","comment":"Entrez Gene ID for the affected gene. References gene.entrez_gene_id."},{"name":"gene_panel_stable_id","type":"LowCardinality(String)","comment":"Identifier of the gene panel used for this sample. Defaults to \"WES\" (Whole Exome Sequencing) when no specific panel is assigned."},{"name":"cancer_study_identifier","type":"LowCardinality(String)","comment":"Stable string identifier for the cancer study. References cancer_study.cancer_study_identifier."},{"name":"genetic_profile_stable_id","type":"LowCardinality(String)","comment":"Stable identifier of the genetic profile containing this event. References genetic_profile.stable_id."},{"name":"variant_type","type":"LowCardinality(String)","comment":"Type of genomic variant: \"mutation\" for point mutations/indels, \"cna\" for copy number alterations, \"structural_variant\" for structural rearrangements."},{"name":"mutation_variant","type":"String","comment":"Protein-level change for mutations (e.g., p.V600E). Set to \"NA\" for non-mutation events. References mutation_event.protein_change."},{"name":"mutation_type","type":"LowCardinality(String)","comment":"Classification of mutation type (e.g., Missense, Nonsense, Frame_Shift). Set to \"NA\" for non-mutation events. References mutation_event.mutation_type."},{"name":"mutation_status","type":"LowCardinality(String)","comment":"Mutation status: Germline, Somatic, or LOH. Set to \"NA\" for non-mutation events. References mutation.mutation_status."},{"name":"driver_filter","type":"LowCardinality(String)","comment":"Driver annotation filter applied to the alteration. Currently set to \"NA\" for all events (driver annotations not yet implemented)."},{"name":"driver_tiers_filter","type":"LowCardinality(String)","comment":"Driver tiers annotation filter. Currently set to \"NA\" for all events (driver annotations not yet implemented)."},{"name":"cna_alteration","type":"Nullable(Int8)","comment":"Copy number alteration value (e.g., -2 for deep deletion, +2 for amplification). NULL for non-CNA events. References cna_event.alteration."},{"name":"cna_cytoband","type":"String","comment":"Cytogenetic band location of the gene for CNA events. Empty string for non-CNA events. References reference_genome_gene.cytoband."},{"name":"sv_event_info","type":"String","comment":"Additional information about structural variant events. Empty string for non-SV events. References structural_variant.event_info."},{"name":"patient_unique_id","type":"String","comment":"Globally unique patient identifier constructed as cancer_study_identifier + \"_\" + patient.stable_id to ensure uniqueness across all studies."},{"name":"off_panel","type":"Bool","comment":"Boolean flag indicating whether this genomic event occurred in a gene not covered by the associated gene panel (TRUE=off-panel, FALSE=on-panel). Determined by checking presence in gene_panel_to_gene_derived table."}]}
```


Good! The column is `cna_alteration`, not `alteration`. Let me fix the query:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- First, let's identify patients with PIK3CA mutations and PTEN deletions\nWITH patient_alterations AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        hugo_gene_symbol,\n        variant_type,\n        CASE \n            WHEN variant_type = 'mutation' THEN 'mutation'\n            WHEN variant_type = 'cna' AND cna_alteration = -2 THEN 'deletion'\n            ELSE NULL\n        END as alteration_type\n    FROM genomic_event_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND hugo_gene_symbol IN ('PIK3CA', 'PTEN')\n        AND (\n            (variant_type = 'mutation') OR \n            (variant_type = 'cna' AND cna_alteration = -2)\n        )\n),\npatient_groups AS (\n    SELECT \n        patient_unique_id,\n        MAX(CASE WHEN hugo_gene_symbol = 'PIK3CA' AND alteration_type = 'mutation' THEN 1 ELSE 0 END) as has_pik3ca_mut,\n        MAX(CASE WHEN hugo_gene_symbol = 'PTEN' AND alteration_type = 'deletion' THEN 1 ELSE 0 END) as has_pten_del\n    FROM patient_alterations\n    GROUP BY patient_unique_id\n),\npatient_subtypes AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        attribute_value as subtype\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND attribute_name = 'SUBTYPE'\n)\nSELECT \n    CASE \n        WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 1 THEN 'PIK3CA mutation + PTEN deletion'\n        WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 0 THEN 'PIK3CA mutation only'\n        ELSE 'Other'\n    END as patient_group,\n    COUNT(DISTINCT pg.patient_unique_id) as total_patients,\n    SUM(CASE WHEN ps.subtype = 'LumA' THEN 1 ELSE 0 END) as luminal_a_count,\n    ROUND(SUM(CASE WHEN ps.subtype = 'LumA' THEN 1 ELSE 0 END) * 100.0 / COUNT(DISTINCT pg.patient_unique_id), 2) as luminal_a_percentage\nFROM patient_groups pg\nLEFT JOIN patient_subtypes ps ON pg.patient_unique_id = ps.patient_unique_id\nWHERE pg.has_pik3ca_mut = 1\nGROUP BY patient_group\nORDER BY patient_group\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"patient_group":"PIK3CA mutation + PTEN deletion","total_patients":6,"luminal_a_count":0,"luminal_a_percentage":0.0},{"patient_group":"PIK3CA mutation only","total_patients":341,"luminal_a_count":0,"luminal_a_percentage":0.0}]}
```


Interesting - I'm getting 0 luminal A counts. Let me check what the actual subtype values are in the database:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_value as subtype, COUNT(*) as count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n    AND attribute_name = 'SUBTYPE'\nGROUP BY attribute_value\nORDER BY count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"subtype":"BRCA_LumA","count":499},{"subtype":"BRCA_LumB","count":197},{"subtype":"BRCA_Basal","count":171},{"count":117},{"subtype":"BRCA_Her2","count":78},{"subtype":"BRCA_Normal","count":36}]}
```


Ah! The subtype values are prefixed with "BRCA_". Let me update the query:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Identify patients with PIK3CA mutations and PTEN deletions and their subtypes\nWITH patient_alterations AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        hugo_gene_symbol,\n        variant_type,\n        CASE \n            WHEN variant_type = 'mutation' THEN 'mutation'\n            WHEN variant_type = 'cna' AND cna_alteration = -2 THEN 'deletion'\n            ELSE NULL\n        END as alteration_type\n    FROM genomic_event_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND hugo_gene_symbol IN ('PIK3CA', 'PTEN')\n        AND (\n            (variant_type = 'mutation') OR \n            (variant_type = 'cna' AND cna_alteration = -2)\n        )\n),\npatient_groups AS (\n    SELECT \n        patient_unique_id,\n        MAX(CASE WHEN hugo_gene_symbol = 'PIK3CA' AND alteration_type = 'mutation' THEN 1 ELSE 0 END) as has_pik3ca_mut,\n        MAX(CASE WHEN hugo_gene_symbol = 'PTEN' AND alteration_type = 'deletion' THEN 1 ELSE 0 END) as has_pten_del\n    FROM patient_alterations\n    GROUP BY patient_unique_id\n),\npatient_subtypes AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        attribute_value as subtype\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND attribute_name = 'SUBTYPE'\n)\nSELECT \n    CASE \n        WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 1 THEN 'PIK3CA mutation + PTEN deletion'\n        WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 0 THEN 'PIK3CA mutation only'\n        ELSE 'Other'\n    END as patient_group,\n    COUNT(DISTINCT pg.patient_unique_id) as total_patients,\n    SUM(CASE WHEN ps.subtype = 'BRCA_LumA' THEN 1 ELSE 0 END) as luminal_a_count,\n    ROUND(SUM(CASE WHEN ps.subtype = 'BRCA_LumA' THEN 1 ELSE 0 END) * 100.0 / COUNT(DISTINCT pg.patient_unique_id), 2) as luminal_a_percentage\nFROM patient_groups pg\nLEFT JOIN patient_subtypes ps ON pg.patient_unique_id = ps.patient_unique_id\nWHERE pg.has_pik3ca_mut = 1\nGROUP BY patient_group\nORDER BY patient_group\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"patient_group":"PIK3CA mutation + PTEN deletion","total_patients":6,"luminal_a_count":3,"luminal_a_percentage":50.0},{"patient_group":"PIK3CA mutation only","total_patients":341,"luminal_a_count":234,"luminal_a_percentage":68.62}]}
```


Excellent! Now let me get more detailed information including the distribution of all subtypes for both groups:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Detailed subtype distribution for PIK3CA mutation groups\nWITH patient_alterations AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        hugo_gene_symbol,\n        variant_type,\n        CASE \n            WHEN variant_type = 'mutation' THEN 'mutation'\n            WHEN variant_type = 'cna' AND cna_alteration = -2 THEN 'deletion'\n            ELSE NULL\n        END as alteration_type\n    FROM genomic_event_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND hugo_gene_symbol IN ('PIK3CA', 'PTEN')\n        AND (\n            (variant_type = 'mutation') OR \n            (variant_type = 'cna' AND cna_alteration = -2)\n        )\n),\npatient_groups AS (\n    SELECT \n        patient_unique_id,\n        MAX(CASE WHEN hugo_gene_symbol = 'PIK3CA' AND alteration_type = 'mutation' THEN 1 ELSE 0 END) as has_pik3ca_mut,\n        MAX(CASE WHEN hugo_gene_symbol = 'PTEN' AND alteration_type = 'deletion' THEN 1 ELSE 0 END) as has_pten_del\n    FROM patient_alterations\n    GROUP BY patient_unique_id\n),\npatient_subtypes AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        attribute_value as subtype\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND attribute_name = 'SUBTYPE'\n)\nSELECT \n    CASE \n        WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 1 THEN 'PIK3CA mutation + PTEN deletion'\n        WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 0 THEN 'PIK3CA mutation only'\n    END as patient_group,\n    COALESCE(ps.subtype, 'Unknown') as subtype,\n    COUNT(*) as count,\n    ROUND(COUNT(*) * 100.0 / SUM(COUNT(*)) OVER (PARTITION BY \n        CASE \n            WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 1 THEN 'PIK3CA mutation + PTEN deletion'\n            WHEN pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 0 THEN 'PIK3CA mutation only'\n        END\n    ), 2) as percentage\nFROM patient_groups pg\nLEFT JOIN patient_subtypes ps ON pg.patient_unique_id = ps.patient_unique_id\nWHERE pg.has_pik3ca_mut = 1\nGROUP BY patient_group, subtype\nORDER BY patient_group, count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"patient_group":"PIK3CA mutation + PTEN deletion","subtype":"BRCA_LumA","count":3,"percentage":50.0},{"patient_group":"PIK3CA mutation + PTEN deletion","subtype":"BRCA_LumB","count":2,"percentage":33.33},{"patient_group":"PIK3CA mutation + PTEN deletion","subtype":"BRCA_Basal","count":1,"percentage":16.67},{"patient_group":"PIK3CA mutation only","subtype":"BRCA_LumA","count":234,"percentage":68.62},{"patient_group":"PIK3CA mutation only","subtype":"BRCA_LumB","count":57,"percentage":16.72},{"patient_group":"PIK3CA mutation only","subtype":"BRCA_Her2","count":26,"percentage":7.62},{"patient_group":"PIK3CA mutation only","subtype":"BRCA_Basal","count":11,"percentage":3.23},{"patient_group":"PIK3CA mutation only","subtype":"BRCA_Normal","count":8,"percentage":2.35},{"patient_group":"PIK3CA mutation only","count":5,"percentage":1.47}]}
```


Perfect! Now let me also check if this difference is statistically significant by running a Fisher's exact test calculation:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Summary statistics for statistical testing\nWITH patient_alterations AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        hugo_gene_symbol,\n        variant_type,\n        CASE \n            WHEN variant_type = 'mutation' THEN 'mutation'\n            WHEN variant_type = 'cna' AND cna_alteration = -2 THEN 'deletion'\n            ELSE NULL\n        END as alteration_type\n    FROM genomic_event_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND hugo_gene_symbol IN ('PIK3CA', 'PTEN')\n        AND (\n            (variant_type = 'mutation') OR \n            (variant_type = 'cna' AND cna_alteration = -2)\n        )\n),\npatient_groups AS (\n    SELECT \n        patient_unique_id,\n        MAX(CASE WHEN hugo_gene_symbol = 'PIK3CA' AND alteration_type = 'mutation' THEN 1 ELSE 0 END) as has_pik3ca_mut,\n        MAX(CASE WHEN hugo_gene_symbol = 'PTEN' AND alteration_type = 'deletion' THEN 1 ELSE 0 END) as has_pten_del\n    FROM patient_alterations\n    GROUP BY patient_unique_id\n),\npatient_subtypes AS (\n    SELECT DISTINCT\n        patient_unique_id,\n        attribute_value as subtype\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'brca_tcga_pan_can_atlas_2018'\n        AND attribute_name = 'SUBTYPE'\n)\nSELECT \n    'PIK3CA + PTEN deletion' as group_name,\n    COUNT(*) as total,\n    SUM(CASE WHEN ps.subtype = 'BRCA_LumA' THEN 1 ELSE 0 END) as luminal_a,\n    SUM(CASE WHEN ps.subtype != 'BRCA_LumA' OR ps.subtype IS NULL THEN 1 ELSE 0 END) as not_luminal_a\nFROM patient_groups pg\nLEFT JOIN patient_subtypes ps ON pg.patient_unique_id = ps.patient_unique_id\nWHERE pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 1\n\nUNION ALL\n\nSELECT \n    'PIK3CA only' as group_name,\n    COUNT(*) as total,\n    SUM(CASE WHEN ps.subtype = 'BRCA_LumA' THEN 1 ELSE 0 END) as luminal_a,\n    SUM(CASE WHEN ps.subtype != 'BRCA_LumA' OR ps.subtype IS NULL THEN 1 ELSE 0 END) as not_luminal_a\nFROM patient_groups pg\nLEFT JOIN patient_subtypes ps ON pg.patient_unique_id = ps.patient_unique_id\nWHERE pg.has_pik3ca_mut = 1 AND pg.has_pten_del = 0\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"group_name":"PIK3CA only","total":341,"luminal_a":234,"not_luminal_a":107},{"group_name":"PIK3CA + PTEN deletion","total":6,"luminal_a":3,"not_luminal_a":3}]}
```


Excellent! Now I have all the data I need. Let me provide a comprehensive answer:

## Analysis Results: PIK3CA Mutations, PTEN Deletions, and Luminal A Subtype in TCGA Breast Cancer

Based on the **TCGA Breast Invasive Carcinoma (PanCancer Atlas)** study with 1,085 samples, here are my findings:

### Key Findings:

**1. Patients with PIK3CA mutation + PTEN deletion:**
- **Total patients:** 6
- **Luminal A subtype:** 3 patients (50.0%)
- **Other subtypes:** 3 patients (50.0%)
  - Luminal B: 2 patients (33.33%)
  - Basal: 1 patient (16.67%)

**2. Patients with PIK3CA mutation only (no PTEN deletion):**
- **Total patients:** 341
- **Luminal A subtype:** 234 patients (68.62%)
- **Other subtypes:** 107 patients (31.38%)
  - Luminal B: 57 patients (16.72%)
  - HER2-enriched: 26 patients (7.62%)
  - Basal: 11 patients (3.23%)
  - Normal-like: 8 patients (2.35%)
  - Unknown: 5 patients (1.47%)

### Answer to Your Questions:

**Q1: What is the probability of luminal A subtype with both PIK3CA mutation and PTEN deletion?**
- **50.0%** (3 out of 6 patients)

**Q2: Is this different from patients with only PIK3CA mutation?**
- **Yes, it appears lower.** Patients with PIK3CA mutation alone have a **68.62%** probability of being luminal A subtype.
- This represents an **18.62 percentage point decrease** when PTEN deletion is also present.

### Important Caveats:

1. **Small sample size:** Only 6 patients have both PIK3CA mutation and PTEN deletion, which limits statistical power. The confidence interval for this estimate would be quite wide.

2. **Statistical significance:** With such a small sample size (n=6), it's difficult to determine if this difference is statistically significant or due to chance. A Fisher's exact test would be needed, but the small numbers suggest caution in interpretation.

3. **Biological context:** PIK3CA mutations are common in ER+ luminal tumors (~35% frequency), while PTEN loss is associated with more aggressive phenotypes and PI3K pathway activation. The co-occurrence of both alterations might shift tumors toward more aggressive subtypes.

The data suggests a trend toward lower luminal A prevalence when PTEN deletion accompanies PIK3CA mutation, but the small sample size prevents definitive conclusions.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 72.8907645069994
- **agent_type**: mcp-clickhouse

### Usage
- **input_tokens**: 105785
- **output_tokens**: 5450
- **total_tokens**: 111235
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 13:37:31*